title: Brain natriuretic peptide level as marker of cardiac function in imatinib--treated chronic myeloid leukemia patients: no evidence of cardiotoxicity of imatinib therapy.
authors.forename: Mario
authors.initials: M
authors.lastname: Tiribelli
authors.forename: Antonio
authors.initials: A
authors.lastname: Colatutto
authors.forename: Luciana
authors.initials: L
authors.lastname: Marin
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Barbina
authors.forename: Ugo
authors.initials: U
authors.lastname: Qualizza
authors.forename: Daniela
authors.initials: D
authors.lastname: Damiani
authors.forename: Eleonora
authors.initials: E
authors.lastname: Toffoletti
authors.forename: Marta
authors.initials: M
authors.lastname: Medeot
authors.forename: Anna
authors.initials: A
authors.lastname: Candoni
authors.forename: Elio
authors.initials: E
authors.lastname: Tonutti
authors.forename: Pierguido
authors.initials: P
authors.lastname: Sala
authors.forename: Renato
authors.initials: R
authors.lastname: Fanin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001549:Benzamides; D054715:Cardiotoxins; D005260:Female; D006334:Heart Function Tests; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D001549:Benzamides; D054715:Cardiotoxins; D010879:Piperazines; D011743:Pyrimidines; D020097:Natriuretic Peptide, Brain; D000068877:Imatinib Mesylate